What is the main purpose of this 8-K filing?

The primary purpose of this 8-K filing is to disclose the issuance of five warrants to an institutional investor as part of a strategic arrangement. It details the terms of these warrants, including the number of shares they are exercisable for, the exercise price, vesting schedule, and anti-dilution provisions.

What is the potential impact on APO's share count?

If all five warrants are exercised, they represent the potential for an additional 13 million shares (5 warrants * 2.6 million shares/warrant) of Apollo Global Management's common stock to be issued. This could lead to significant dilution for existing shareholders, depending on the company's stock price and market conditions at the time of exercise.

How will the exercise of these warrants affect existing shareholders?

The exercise of these warrants, especially if settled through the issuance of new shares, will dilute the ownership stake of existing shareholders. The anti-dilution clauses are designed to protect the warrant holder's investment, meaning adjustments could increase the number of shares or decrease the exercise price under certain circumstances, potentially exacerbating dilution.

APO 8-K: Securities & Listing

Q: When can these warrants be exercised?

The first warrant is exercisable immediately from the issuance date (February 15, 2022). The remaining four warrants have staggered exercisability, becoming exercisable on the first, second, third, and fourth anniversaries of the issuance date, respectively. All warrants expire five years from the issuance date, with automatic exercise if the stock price is above the exercise price at expiration.

Summary

Apollo Global Management, Inc. (APO) filed an 8-K on February 22, 2022, primarily disclosing the issuance of five warrants to an institutional investor as part of a strategic arrangement. These warrants are exercisable for a significant number of shares of APO common stock, with specific exercise prices and vesting schedules. This issuance was conducted under Section 4(a)(2) of the Securities Act of 1933, indicating an unregistered private placement. The warrants contain anti-dilution provisions to protect the investor and are subject to cashless net exercise upon vesting. Investors should note the potential future dilution and the terms of these warrants, which could impact the stock's trading dynamics. The warrants are structured with staggered exercisability, with the first exercisable immediately and subsequent warrants becoming exercisable on the first, second, third, and fourth anniversaries of the issuance date. They expire five years from issuance, with automatic exercise if the stock price exceeds the exercise price at expiration. The exercise price is $82.80 per share, and each warrant is exercisable for 2.6 million shares, subject to anti-dilution adjustments. This transaction, while not immediately impacting current shareholders through new share issuance, represents a significant contingent claim on the company's equity.

Key Highlights

1Apollo Global Management (APO) issued five warrants to an institutional investor on February 15, 2022, under a strategic arrangement.
2Each warrant is exercisable for 2.6 million shares of APO common stock, totaling a potential 13 million shares if all warrants are exercised.
3The exercise price for each warrant is set at $82.80 per share.
4Warrants are subject to customary anti-dilution provisions to protect the investor.
5The first warrant is exercisable immediately, with subsequent warrants vesting annually over four years.
6Warrants expire on the fifth anniversary of issuance, with automatic cashless net exercise if the stock price is above the exercise price.
7The issuance was conducted as a private placement under Section 4(a)(2) of the Securities Act, meaning it was unregistered.

Apollo Global Management, Inc. 8-K Report, Unregistered Securities Sale (Feb 22, 2022)

Summary

Key Highlights

Frequently Asked Questions